Clinical Drug Experience Knowledgebase

alemtuzumab (campath) (1 trial)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

asparaginase (elspar) (2 trials)

autologous hematopoietic cell (1 trial)

cyclophosphamide (cytoxan) (2 trials)

daunorubicin (cerubidine) (2 trials)

etoposide (vepesid) (1 trial)

fludarabine (fludara) (2 trials)

idarubicin (idamycin) (1 trial)

imatinib (gleevec) (1 trial)

lenalidomide (revlimid) (1 trial)

mercaptopurine (purinethol) (2 trials)

methylprednisolone (medrol) (2 trials)

mitoxantrone (novantrone) (1 trial)

naltrexone (revia) (2 trials)

peripheral blood hematopoietic cell (1 trial)

prednisone (meticorten) (2 trials)

vincristine (oncovin) (2 trials)

cytarabine (cytosar-u) (1 trial)

doxorubicin (Doxil) (1 trial)

ifosfamide (ifex) (1 trial)

tioguanine (Lanvis) (1 trial)

urea (1 trial)